Allergic rhinitis and allergic conjunctivitis: one disease - two clinical forms
- Authors: Kurbacheva OM1, Pavlova KS1
-
Affiliations:
- Institute of Immunology
- Issue: Vol 12, No 3 (2015)
- Pages: 22-29
- Section: Articles
- URL: https://bakhtiniada.ru/raj/article/view/120760
- DOI: https://doi.org/10.36691/RJA441
- ID: 120760
Cite item
Open Access
Access granted
Subscription Access
Abstract
This paper has summarized some questions of allergic rhinitis and allergic conjunctivitis classification, diagnosis and treatment. The rapid onset of effect, high efficiency and low bioavailability determine the feasibility of local antihistamines to treat AR and AK, especially in case of a local failure.
Full Text
##article.viewOnOriginalSite##About the authors
O M Kurbacheva
Institute of Immunology
Email: kurbacheva@gmail.com
K S Pavlova
Institute of Immunology
References
- Ильина Н.И. Аллергология в различных регионах России по результатам клинико-эпидемиологических исследований. Диссертация д-ра мед. наук. М., 1996, 225 с.
- Патерсон Р., Грэммер Л.К., Гринберг П.А. Аллергические болезни: диагностика и лечение. Пер. с англ. Под ред. А.Г. Чучалина, И.С. Гущина, Э.Г. Улумбекова, Р.С. Фассахова. М., «ГЭОТАР МЕДИЦИНА». 2000, 768 с.
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy. 2008, v. 63, p. 1-160.
- Lundbäck B. Epidemiology of allergic rhinitis and asthma. Clin. Exp. Allergy. 1998, v. 28, p. 3-10.
- Van Cauwenberge P.B., Ciprandi G., Vermeiren J.S.J. Epidemiology of allergic rhinitis. The UCB Institute of Allergy. 2001, 27 p.
- Naclerio R.M., Pinto J., de Tineo M., Baroody F.M. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008, v. 29, p. 24-28.
- Майчук Д.Ю., Куренков В.В., Кашникова О.А. В кн. «Актуальные вопросы воспалительных заболеваний глаз». М., «Наука». 2001, c. 232-234.
- Майчук Ю.Ф. Современные аспекты фармакотерапии глазных аллергозов. Вестник офтальмологии. 2000, № 5, с. 10-14.
- Гущин И.С., Курбачева О.М. Аллергия и аллергенспецифическая иммунотерапия. М., «Фармарус Принт Медиа». 2010, 228 с.
- Akiyoshi M., Shigeoka T., Torii S. et al. Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective ^-antagonist. Nippon Yakurigaku Zasshi. 2002, v. 119, p. 175-184.
- Noble S., McTavich D. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs. 1995, v. 50, p. 1032-1049.
- Okubo K., Uchida E., Nogami S. Levocabastine nasal spray significantly improves perennial allergic rhinitis: A single-blind placebo-controlled study. Auris Nasus Larynx. 2010, v. 37, p. 436-442.
- Mösges R., Spaeth J., Klimek L. Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis. Mediators of Inflammation. 1995, v. 4, p. 11-15.
- Kawakita T., Takano Y., Tanaka M. et al. Cromoglicic acid ophthalmic solution 2% versus levocabastine ophthalmic suspension 0,025% in the treatment of allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci. 2002, v. 43, E-Abstract 3168.
- LePen C., Smith A.F., Lilliu H., Priol G. Note on a method to derive an aggregated score for assessing treatment efficacy in Seasonal Allergic Conjunctivitis. J. Clinical Drug Investigation. 2002, v. 22, p. 783-789.
- Ahluwalia P., Anderson D.F., Wilson S.J. et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. J. Allergy and Clin. Immunol. 2001, v. 108, p. 449-454.
Supplementary files
